Biotechnology:-Commercial-Physical-&-Biological-Resarch (19)
| Company | Ticker | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|---|
| MAINZ BIOMED B.V. | MYNZ | 0% | 0% | 276% | -84% | -32% |
| AbSci Corp. | ABSI | 0% | 24% | -38% | 100% | -74% |
| Happiness Biotech Group Limited | HAPP | 0% | 2% | -48% | -44% | 663% |
| NanoViricides Inc | NNVC | 0% | 4% | 0% | 0% | -59% |
| IQVIA Holdings Inc | IQV | 0% | 1% | -15% | 13% | -27% |
| Charles River Laboratories International Inc | CRL | 0% | 1% | -22% | 8% | -42% |
| Tenax Therapeutics Inc | TENX | 0% | 0% | 0% | 0% | -89% |
| Syneos Health Inc | SYNH | 0% | 0% | 0% | 25% | -67% |
| Sorrento Therapeutics Inc | SRNE | 0% | 0% | 0% | -65% | -81% |
| Pieris Pharmaceuticals Inc | PIRS | 0% | 0% | -21% | -83% | -72% |
| National Research Corporation | NRC | 0% | 1% | -55% | 6% | -10% |
| Luna Innovations Incorporated | LUNA | 0% | -6% | -67% | -24% | 4% |
| Incyte Corporation | INCY | 0% | 1% | 10% | -22% | 9% |
| ICON plc | ICLR | 0% | 2% | -26% | 46% | -37% |
| Exelixis Inc | EXEL | 0% | 2% | 39% | 50% | -12% |
| Exact Sciences Corporation | EXAS | 0% | 2% | -24% | 61% | -41% |
| Eloxx Pharmaceuticals Inc | ELOX | 0% | 0% | 0% | 113% | 152% |
| Anavex Life Sciences Corp | AVXL | 0% | 15% | 15% | 1% | -47% |
| Medpace Holdings Inc. | MEDP | 0% | 3% | 8% | 44% | -2% |